Pillstats
Rx only · Powder, For Suspension · Oral

Hydrochlorothiazide

Brands: Inzirqo · Hydrochlorothiazide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03AA03
RxCUI (US)5487
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.28$2.56$3.85$5.13Feb 2026May 2026Jul 2026
$4.457
Latest avg · Jul 22, 2026
+0%
Since Feb 18, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5241.0K1.6K2.1K2025 Q22025 Q32025 Q42026 Q1
1.8K
Rx · 2026 Q1
154K
Units dispensed
4
Quarters · since 2025 Q2

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ANI Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.